GlassScriptPhysician profile
Lisa M Breuner
NPI 1215940283
$3,144.47
in general payments reported to CMS, 2019-2025
23 companies · $82.40 in 2025
The $82.40 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $333 · 2021: $441 · 2022: $354 · 2023: $187 · 2024: $307 · 2025: $82.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $1,147.69 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $633.84 | 2019-2025 | Collagenase Santyl |
| Horizon Therapeutics Plc | $204.95 | 2019-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $173.96 | 2019-2021 | |
| Bone Support INC. | $146.48 | 2024 | Cerament G, Ceramentbone Void Filler |
| Musculoskeletal Transplant Foundation INC. | $97.86 | 2021-2022 | |
| Nevro Corp. | $87.68 | 2022 | |
| Organogenesis INC. | $85.36 | 2019-2023 | Puraply |
| Alfasigma USA, INC. | $78.71 | 2021-2022 | |
| Amgen INC. | $75.75 | 2024 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.09 | 2020-2023 | Jublia |
| Orthofix Medical, INC. | $55.04 | 2021-2022 | |
| Ibsa Pharma INC. | $52.69 | 2021 | |
| Abbott Laboratories | $48.54 | 2021 | |
| Mayne Pharma Commercial LLC | $48.52 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $25.76 | 2020 | |
| Melinta Therapeutics, LLC | $24.93 | 2019 | |
| Mimedx Group, INC. | $22.18 | 2024 | |
| Pfizer INC. | $16.32 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.04 | 2020 | |
| Treace Medical Concepts, INC. | $14.46 | 2023 | |
| Integra Lifesciences Corporation | $11.73 | 2019 | |
| Zyla Life Sciences, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Breuner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.